Detecting lead exposure using nail specimens
Identification of breast and urinary cancer, among others
SLYME - Overview: Lyme Antibody Modified 2-Tier with Reflex, Serum
Diagnosis of Lyme disease This test should not be used as a screening procedure for the general population.
DCTR - Overview: Direct Antiglobulin Test (Polyspecific), Blood
Demonstrating in vivo coating of red blood cells with IgG or the complement component C3d in the following settings: -Autoimmune hemolytic anemia -Hemolytic transfusion reactions -Drug-induced hemolytic anemia
CDP - Overview: Chlordiazepoxide and Metabolite, Serum
Monitoring chlordiazepoxide therapy Assessing toxicity
DIA - Overview: Diazepam and Nordiazepam, Serum
Assessing compliance Monitoring for appropriate therapeutic level Assessing diazepam toxicity
HKC - Overview: Hexokinase Enzyme Activity, Blood
The evaluation of individuals with Coombs-negative chronic hemolysis
LEU - Overview: Fecal Leukocytes, Feces
Suggesting the presence of pathogens such as Salmonella, Shigella, and amebiasis
PBOU - Overview: Lead Occupational Exposure, Random, Urine
Detecting clinically significant lead exposure due to occupational exposure in random urine specimens This test is not a substitute for blood lead screening.
MONOS - Overview: Infectious Mononucleosis, Rapid Test, Serum
Diagnosis of Epstein-Barr virus mononucleosis
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....
Week in Review: November 1 - Insights
Top highlights include: Facebook launches into the digital space of healthcare, medical breakthrough for Ebola, and how the brain makes memories.